These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 25095523

  • 1. Incidence and hazards of alloantibodies in renal transplantation.
    Everly MJ.
    Clin Transpl; 2013; ():313-7. PubMed ID: 25095523
    [Abstract] [Full Text] [Related]

  • 2. A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.
    Rebellato LM, Everly MJ, Haisch CE, Ozawa M, Briley KP, Parker K, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC.
    Clin Transpl; 2011; ():337-40. PubMed ID: 22755428
    [Abstract] [Full Text] [Related]

  • 3. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.
    Everly MJ, Rebellato LM, Haisch CE, Ozawa M, Parker K, Briley KP, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI.
    Transplantation; 2013 Feb 15; 95(3):410-7. PubMed ID: 23380861
    [Abstract] [Full Text] [Related]

  • 4. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y, Ramon D, Luan FL, Sung R, Samaniego M.
    Clin Transpl; 2012 Feb 15; ():247-56. PubMed ID: 23721029
    [Abstract] [Full Text] [Related]

  • 5. Donor specific antibodies before and after kidney transplant: the University of Colorado Experience.
    Cooper JE, Gralla J, Adebiyi O, Wiseman AC, Chan L.
    Clin Transpl; 2013 Feb 15; ():407-12. PubMed ID: 25095536
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY, Kaneku H, Farmer DG.
    Clin Transpl; 2014 Feb 15; ():153-9. PubMed ID: 26281140
    [Abstract] [Full Text] [Related]

  • 13. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.
    Dieplinger G, Ditt V, Arns W, Huppertz A, Kisner T, Hellmich M, Bauerfeind U, Stippel DL.
    Transpl Int; 2014 Jan 15; 27(1):60-8. PubMed ID: 24131087
    [Abstract] [Full Text] [Related]

  • 14. Trends and characteristics in early glomerular filtration rate decline after posttransplantation alloantibody appearance.
    Wu P, Everly MJ, Rebellato LM, Haisch CE, Briley KP, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Harland RC, Terasaki PI.
    Transplantation; 2013 Nov 27; 96(10):919-25. PubMed ID: 23912173
    [Abstract] [Full Text] [Related]

  • 15. Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients.
    Everly MJ, Rebellato LM, Haisch CE, Briley KP, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Maldonado AQ, Harland RC, Terasaki PI.
    Transplantation; 2014 Mar 15; 97(5):494-501. PubMed ID: 24487396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.